Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CCM vs USPH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CCM
Concord Medical Services Holdings Limited

Medical - Care Facilities

HealthcareNYSE • CN
Market Cap$748K
5Y Perf.-63.0%
USPH
U.S. Physical Therapy, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$897M
5Y Perf.-20.4%

CCM vs USPH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CCM logoCCM
USPH logoUSPH
IndustryMedical - Care FacilitiesMedical - Care Facilities
Market Cap$748K$897M
Revenue (TTM)$366M$695M
Net Income (TTM)$-163M$11M
Gross Margin-11.4%22.0%
Operating Margin-131.0%12.2%
Forward P/E1.2x20.6x
Total Debt$3.93B$426M
Cash & Equiv.$216M$36M

CCM vs USPHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CCM
USPH
StockMay 20May 26Return
Concord Medical Ser… (CCM)10037.0-63.0%
U.S. Physical Thera… (USPH)10079.6-20.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: CCM vs USPH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: USPH leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Concord Medical Services Holdings Limited is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CCM
Concord Medical Services Holdings Limited
The Income Pick

CCM is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 0 yrs, beta 0.53
  • Lower volatility, beta 0.53, current ratio 0.46x
  • Beta 0.53, current ratio 0.46x
Best for: income & stability and sleep-well-at-night
USPH
U.S. Physical Therapy, Inc.
The Growth Play

USPH carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 16.3%, EPS growth -22.8%, 3Y rev CAGR 12.2%
  • 22.6% 10Y total return vs CCM's -88.8%
  • 16.3% revenue growth vs CCM's -28.6%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthUSPH logoUSPH16.3% revenue growth vs CCM's -28.6%
ValueCCM logoCCMLower P/E (1.2x vs 20.6x)
Quality / MarginsUSPH logoUSPH1.5% margin vs CCM's -44.6%
Stability / SafetyCCM logoCCMBeta 0.53 vs USPH's 0.93
DividendsUSPH logoUSPH3.1% yield; 5-year raise streak; the other pay no meaningful dividend
Momentum (1Y)USPH logoUSPH-14.3% vs CCM's -28.4%
Efficiency (ROA)USPH logoUSPH0.9% ROA vs CCM's -2.4%, ROIC 5.6% vs -7.7%

CCM vs USPH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CCMConcord Medical Services Holdings Limited
FY 2024
Services and other revenues
80.1%$372M
Medicine income
17.9%$83M
Equipment Leasing Revenues
2.0%$9M
USPHU.S. Physical Therapy, Inc.
FY 2025
Net Patient Revenues
83.3%$650M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
16.7%$131M

CCM vs USPH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUSPHLAGGINGCCM

Income & Cash Flow (Last 12 Months)

USPH leads this category, winning 5 of 6 comparable metrics.

USPH is the larger business by revenue, generating $695M annually — 1.9x CCM's $366M. USPH is the more profitable business, keeping 1.5% of every revenue dollar as net income compared to CCM's -44.6%. On growth, USPH holds the edge at +7.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCCM logoCCMConcord Medical S…USPH logoUSPHU.S. Physical The…
RevenueTrailing 12 months$366M$695M
EBITDAEarnings before interest/tax-$359M$107M
Net IncomeAfter-tax profit-$163M$11M
Free Cash FlowCash after capex$0$67M
Gross MarginGross profit ÷ Revenue-11.4%+22.0%
Operating MarginEBIT ÷ Revenue-131.0%+12.2%
Net MarginNet income ÷ Revenue-44.6%+1.5%
FCF MarginFCF ÷ Revenue-2.1%+9.6%
Rev. Growth (YoY)Latest quarter vs prior year-8.3%+7.7%
EPS Growth (YoY)Latest quarter vs prior year+84.0%-115.0%
USPH leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

CCM leads this category, winning 4 of 4 comparable metrics.
MetricCCM logoCCMConcord Medical S…USPH logoUSPHU.S. Physical The…
Market CapShares × price$748,461$897M
Enterprise ValueMkt cap + debt − cash$547M$1.3B
Trailing P/EPrice ÷ TTM EPS-0.02x41.55x
Forward P/EPrice ÷ next-FY EPS est.1.23x20.63x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple12.52x
Price / SalesMarket cap ÷ Revenue0.01x1.15x
Price / BookPrice ÷ Book value/share0.00x1.16x
Price / FCFMarket cap ÷ FCF14.71x
CCM leads this category, winning 4 of 4 comparable metrics.

Profitability & Efficiency

USPH leads this category, winning 9 of 9 comparable metrics.

USPH delivers a 1.4% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $-10 for CCM. USPH carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCM's 2.43x. On the Piotroski fundamental quality scale (0–9), USPH scores 5/9 vs CCM's 3/9, reflecting solid financial health.

MetricCCM logoCCMConcord Medical S…USPH logoUSPHU.S. Physical The…
ROE (TTM)Return on equity-9.8%+1.4%
ROA (TTM)Return on assets-2.4%+0.9%
ROICReturn on invested capital-7.7%+5.6%
ROCEReturn on capital employed-12.2%+7.6%
Piotroski ScoreFundamental quality 0–935
Debt / EquityFinancial leverage2.43x0.55x
Net DebtTotal debt minus cash$3.7B$390M
Cash & Equiv.Liquid assets$216M$36M
Total DebtShort + long-term debt$3.9B$426M
Interest CoverageEBIT ÷ Interest expense-2.40x15.42x
USPH leads this category, winning 9 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

USPH leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in USPH five years ago would be worth $5,664 today (with dividends reinvested), compared to $1,512 for CCM. Over the past 12 months, USPH leads with a -14.3% total return vs CCM's -28.4%. The 3-year compound annual growth rate (CAGR) favors USPH at -17.4% vs CCM's -27.2% — a key indicator of consistent wealth creation.

MetricCCM logoCCMConcord Medical S…USPH logoUSPHU.S. Physical The…
YTD ReturnYear-to-date+20.4%-24.6%
1-Year ReturnPast 12 months-28.4%-14.3%
3-Year ReturnCumulative with dividends-61.4%-43.7%
5-Year ReturnCumulative with dividends-84.9%-43.4%
10-Year ReturnCumulative with dividends-88.8%+22.6%
CAGR (3Y)Annualised 3-year return-27.2%-17.4%
USPH leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CCM and USPH each lead in 1 of 2 comparable metrics.

CCM is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than USPH's 0.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. USPH currently trades 63.1% from its 52-week high vs CCM's 47.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCCM logoCCMConcord Medical S…USPH logoUSPHU.S. Physical The…
Beta (5Y)Sensitivity to S&P 5000.53x0.93x
52-Week HighHighest price in past year$10.77$93.50
52-Week LowLowest price in past year$3.18$58.55
% of 52W HighCurrent price vs 52-week peak+47.7%+63.1%
RSI (14)Momentum oscillator 0–10067.546.1
Avg Volume (50D)Average daily shares traded11K171K
Evenly matched — CCM and USPH each lead in 1 of 2 comparable metrics.

Analyst Outlook

USPH leads this category, winning 1 of 1 comparable metric.

Wall Street rates CCM as "Buy" and USPH as "Buy". USPH is the only dividend payer here at 3.06% yield — a key consideration for income-focused portfolios.

MetricCCM logoCCMConcord Medical S…USPH logoUSPHU.S. Physical The…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$102.00
# AnalystsCovering analysts212
Dividend YieldAnnual dividend ÷ price+3.1%
Dividend StreakConsecutive years of raises05
Dividend / ShareAnnual DPS$1.80
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.6%
USPH leads this category, winning 1 of 1 comparable metric.
Key Takeaway

USPH leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CCM leads in 1 (Valuation Metrics). 1 tied.

Best OverallU.S. Physical Therapy, Inc. (USPH)Leads 4 of 6 categories
Loading custom metrics...

CCM vs USPH: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is CCM or USPH a better buy right now?

For growth investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger pick with 16. 3% revenue growth year-over-year, versus -28. 6% for Concord Medical Services Holdings Limited (CCM). U. S. Physical Therapy, Inc. (USPH) offers the better valuation at 41. 5x trailing P/E (20. 6x forward), making it the more compelling value choice. Analysts rate Concord Medical Services Holdings Limited (CCM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CCM or USPH?

On forward P/E, Concord Medical Services Holdings Limited is actually cheaper at 1.

2x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — CCM or USPH?

Over the past 5 years, U.

S. Physical Therapy, Inc. (USPH) delivered a total return of -43. 4%, compared to -84. 9% for Concord Medical Services Holdings Limited (CCM). Over 10 years, the gap is even starker: USPH returned +22. 6% versus CCM's -88. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CCM or USPH?

By beta (market sensitivity over 5 years), Concord Medical Services Holdings Limited (CCM) is the lower-risk stock at 0.

53β versus U. S. Physical Therapy, Inc. 's 0. 93β — meaning USPH is approximately 75% more volatile than CCM relative to the S&P 500. On balance sheet safety, U. S. Physical Therapy, Inc. (USPH) carries a lower debt/equity ratio of 55% versus 2% for Concord Medical Services Holdings Limited — giving it more financial flexibility in a downturn.

05

Which is growing faster — CCM or USPH?

By revenue growth (latest reported year), U.

S. Physical Therapy, Inc. (USPH) is pulling ahead at 16. 3% versus -28. 6% for Concord Medical Services Holdings Limited (CCM). On earnings-per-share growth, the picture is similar: Concord Medical Services Holdings Limited grew EPS -3. 6% year-over-year, compared to -22. 8% for U. S. Physical Therapy, Inc.. Over a 3-year CAGR, USPH leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CCM or USPH?

U.

S. Physical Therapy, Inc. (USPH) is the more profitable company, earning 1. 9% net margin versus -80. 3% for Concord Medical Services Holdings Limited — meaning it keeps 1. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: USPH leads at 10. 3% versus -138. 6% for CCM. At the gross margin level — before operating expenses — USPH leads at 20. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CCM or USPH more undervalued right now?

On forward earnings alone, Concord Medical Services Holdings Limited (CCM) trades at 1.

2x forward P/E versus 20. 6x for U. S. Physical Therapy, Inc. — 19. 4x cheaper on a one-year earnings basis.

08

Which pays a better dividend — CCM or USPH?

In this comparison, USPH (3.

1% yield) pays a dividend. CCM does not pay a meaningful dividend and should not be held primarily for income.

09

Is CCM or USPH better for a retirement portfolio?

For long-horizon retirement investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93), 3. 1% yield). Both have compounded well over 10 years (USPH: +22. 6%, CCM: -88. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CCM and USPH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CCM is a small-cap quality compounder stock; USPH is a small-cap high-growth stock. USPH pays a dividend while CCM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CCM

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

USPH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 13%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CCM and USPH on the metrics below

Revenue Growth>
%
(CCM: -8.3% · USPH: 7.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.